Repligen to Acquire BioLife Solutions for $1.5 Billion
Repligen Corporation (RGEN) entered a merger agreement on July 22, 2026, to acquire BioLife Solutions, Inc. (BLFS) in a deal valued at $1.5 billion. Deal Structure: BioLife…
Written byAsif SuriaSource: InsideArbitrage
Repligen Corporation (RGEN) entered a merger agreement on July 22, 2026, to acquire BioLife Solutions, Inc. (BLFS) in a deal valued at $1.5 billion. Deal Structure: BioLife stockholders will receive $11.25 per share in cash and 0.1442 shares of Repligen common stock, for a total value of $31 per share, representing a 6.2% premium over the